JOSEPH C PAPA
CIK 1242215 · President and CEO · last filed 2026-07-01
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$20.07M
Companies
7
Total Filings
107
Lifetime Open-Market Net
-$40.43M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CADL | Director | 102,271 | $9.68 | $990.0K | $73.1K | 9 | 2026-07-01 |
| MIST | Director | 100,000 | $1.07 | $107.0K | $0 | 4 | 2026-06-12 |
| EBS | President and CEO | 493,153 | $7.31 | $3.60M | $349.8K | 6 | 2026-05-01 |
| Prometheus Biosciences, Inc. (RXDX) Delisted | Director | 0 | $199.92 | $0 | $285.0K | 6 | 2023-06-16 |
| BHC | CHAIRMAN & CEO | 1,395,371 | $4.52 | $6.31M | $2.08M | 18 | 2022-05-12 |
| BLCO | CEO & Chairman | 472,222 | $16.61 | $7.84M | $0 | 1 | 2022-05-09 |
| PRGO | CEO | 118,515 | $10.30 | $1.22M | -$43.21M | 58 | 2016-03-01 |
Recent Filings · Page 4 of 11
107 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-03-10 | BHC | Mixed | +194,155 | -$7.62M | EDGAR |
| 2021-03-05 | BHC | Grant (A) | +74,150 | $0 | EDGAR |
| 2021-03-03 | BHC | Tax (F) | −28,192 | -$885.8K | EDGAR |
| 2020-09-16 | BHC | Tax (F) | −8,738 | -$137.2K | EDGAR |
| 2020-05-06 | BHC | Tax (F) | −95,489 | -$1.64M | EDGAR |
| 2020-03-11 | BHC | Tax (F) | −18,488 | -$387.5K | EDGAR |
| 2020-03-03 | BHC | Tax (F) | −14,194 | -$337.4K | EDGAR |
| 2020-02-28 | BHC | Grant (A) | +81,040 | $0 | EDGAR |
| 2019-09-18 | BHC | Tax (F) | −5,115 | -$118.9K | EDGAR |
| 2019-09-13 | BHC | Mixed | +51,248 | $699.3K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.